Lyme disease, spread by infected ticks, starts with flu-like symptoms but can lead to serious neurological, heart, and joint ...

By the time you graduate medical school, you should have a handle on these chronic diseases, as you’ll likely encounter them ...

A clinical trial is under way for a new treatment for coeliac disease, an autoimmune condition affecting around 20 per cent ...

Novartis’ oral Fabhalta (iptacopan) has been approved by the US Food and Drug Administration (FDA) as the first treatment for ...

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

In Estonia, many people learned a lesson from ethnomedicine as children: that placing a plantain leaf on a scraped knee would ...

Scientists have discovered that the enzyme BbLDH is crucial for the survival and infectivity of the Lyme disease bacterium ...

Patients with moderate to severe Crohn’s disease who did not achieve clinical response to IV induction with Skyrizi ...

Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia ...